Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Temedica Introduces Permea: First Analytics Platform Integrating Patient-Generated Health Data

Published

on

  • Unique real-world data platform integrating proprietary, regulatory-grade, patient-generated health data
  • Permea translates previously inaccessible data into knowledge to provide new medical and scientific insight for stakeholders along the healthcare value chain
  • Permea addresses USD 57 billion real-world evidence market potential with two new collaboration models: Permea Insights and Permea Monitor
  • All Permea operations comply with the German laws on data protection and security (GDPR)

MUNICH, Germany, Jan. 18, 2022 (GLOBE NEWSWIRE) — Temedica GmbH, a leading digital health and data analytics company, today announces the launch of Permea. Permea is a unique platform providing medically sound analyses and actionable insights to a whole range of questions and challenges arising along the value chain in the healthcare market. By combining regulatory-grade, patient-generated data with a variety of readily available scientific and commercial data sources for the first time, Permea provides new insights into therapies and their effects under real-world conditions.

Permea supports biopharma, biotech, and medtech companies, physicians, regulatory authorities, payers, and patients in making knowledge-based decisions for improving therapeutic options. The platform combines, structures, and analyzes data from multiple sources, including proprietary longitudinal patient-generated data from digital health apps and wearables, scientific publications, and prescription data. Permea can uncover the most effective therapy for a defined cohort, identify reasons for a therapy change, and improve current healthcare treatment with new insights. In addition, the platform expands the data provided by clinical trials and supports the planning of new studies. Permea enables more highly informed decisions for new strategies in research and development, regulatory approvals, market launches, and commercialization of therapies. Patients benefit from new knowledge and information on their individual disease progression.

Dr. Benjamin Friedrich, Chief Medical Officer of Temedica, said:

“For the first time, patient-generated data from millions of patients is intelligently combined with other medically relevant data and transformed into applicable knowledge. In this way, we bring the personal experience of patients into real-world evidence analyses. This makes Permea an indispensable and pioneering technology for multiple challenges in the healthcare market. Permea reveals the real stories behind patient data and statistics and is therefore essential for the digital future of personalized medicine.”

Gloria Seibert, Founder & Chief Executive Officer at Temedica, added:

“The launch of Permea is a fundamental step for achieving Temedica’s vision in personalized medicine and opens a billion-dollar market opportunity in real-world evidence. Our technology platform, which leverages unique proprietary data and processes, enables us to form novel alliances with healthcare companies and provides critical momentum to improve care and everyday support for patients around the world. Permea is already delivering valuable insights for informed decision making in therapy development. The initial feedback received from clients and partners is highly encouraging.”

With Permea Insights and Permea Monitor, Temedica currently offers clients two distinct cooperation models:

Permea Insights answers specific questions and provides analytics in the form of customized reports. Permea Insights helps clients better understand patient needs and how therapies and patient behavior influence the entire patient journey. To do this, Permea uses technologies such as machine learning and artificial intelligence. The underlying algorithms enable the integration of multiple data sources in real time. Clients receive tailored analytics and reports to make knowledge-based decisions.

Permea Monitor enables clients to independently perform analyses with Permea datasets and combine them with their own knowledge and data pools. This is based on innovative data science methods and artificial intelligence, embedded in an intuitive user interface. Each Permea Monitor is configured according to specific client needs and provides the data and insights that are crucial for their purposes.

Permea can also optimize clinical trial planning by providing information about the potential therapy effect in defined patient cohorts and can be used for optimization of study planning. Potential for further development and optimization of therapies can be uncovered by showing new correlations of therapy success, cohorts, and symptoms. Analysis of the data may uncover motivations for therapy changes and disease burden, making the platform critical for strategic and trial design planning.

Permea uses long-term historical data from millions of patients to identify characteristics, correlations, anomalies, and differences between patient populations under real-world conditions. Temedica also uses the information obtained through Permea for its digital health apps—the patient companions—thereby offering patients personalized support with individual recommendations.

All international Permea offerings are compliant with the General Data Protection Regulation (GDPR). In generating and processing data, Temedica meets all data protection and security requirements and attaches great importance to transparency towards all stakeholders.

About Permea

Permea is a new offering from Temedica available to different stakeholders in the healthcare space. Permea combines multiple data sources, including longitudinal, patient-generated data with high resolution related to time, geography and patient cohorts. Its customizable solutions provide insights on various questions and challenges along the health care value chain, including research and development, regulatory approvals, market launches and commercialization of therapies. The Permea Insights and Permea Monitor offerings provide in-depth knowledge about therapies and their effects under real-world conditions, enabling more highly informed decisions. Based on artificial intelligence and innovative algorithms, Permea provides answers to industry relevant questions. All Permea operations comply with the General Data Protection Regulation (GDPR) laws on data protection and security and meet the high standards also internationally. For more information, please visit www.permea-health.com.

About Temedica GmbH

Temedica is a Munich, Germany-based digital health company with a mission to bring the patient into the center of healthcare. The company develops state-of-the-art digital patient companions for complex, chronic conditions. These apps support patients with personalized guidance and help them navigate through healthcare systems by considering their individual needs. Through direct and long-term interaction with patients, Temedica generates unique and previously unknown real-world evidence about disease progression and the individual effectiveness of therapies. Temedica has an expertise in the personalized support of patients as well as in compiling, structuring and analyzing respective health data. Its data analytics platform Permea is designed to enable unique insights along the entire healthcare value chain and patient journey. Temedica is supported by a consortium of renowned investors with longstanding track-records in the biopharmaceutical industry, including the founding investors of BioNTech. Further information is available at https://temedica.com/en/.

For further information please contact:
Temedica GmbH
Dr. Benjamin Friedrich, CMO
T +49-89-215544-970
Email: [email protected]

International Media and IR Contact
Dr. Brigitte Keller, Katja Arnold
T +49 89 210228 0
UK: Shaun Brown
M: +44 7867 515 918
Email: [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

HKPC and HP Launch Joint Technology Centre in Hong Kong on Advanced 3D Printing

Published

on

hkpc-and-hp-launch-joint-technology-centre-in-hong-kong-on-advanced-3d-printing

HONG KONG, May 7, 2024 /PRNewswire/ — Hong Kong Productivity Council (HKPC) and HP signed a collaboration agreement (agreement) today to establish the HKPC-HP 3D Printing Technology Centre (Centre) in Hong Kong for application research development on additive manufacturing, also known as 3D printing. The Centre aims to become a pilot transformation base, applying advanced 3D printing technologies to empower various industries, sharpen their competitive edge, and foster the development of high-value strategic industrial chains. It will also accelerate Hong Kong’s pioneering effort in micro-factory and new industrialisation development, offering important references and inspiration worldwide in the pursuit of innovative and sustainable development.

The Centre will be located in the HKPC Building, being the first in Asia to be equipped with both HP’s research version of “Metal Jet” and “Multi Jet Fusion” industrial 3D printers. HP will bring advanced equipment and talent to support the operations of the Centre, and HKPC will contribute expertise in raw material development, process development, and smartification. Market research data estimate that the value of the 3D printing industry will reach US$186.4 billion by 2033, a significant increase from US$27.7 billion in 2023, indicating the immense market potential.
Clean, digitally powered 3D printing generates minimal waste and a minimal carbon footprint. This aligns with global goals of achieving green and sustainable development, while also promoting long-term economic growth through sustainable industries. At the same time, advanced 3D printing provides significant opportunities in strategic industries, such as healthtech, critical components, electronics, and more. In the future, the Centre, with its focus on customisation and precision, can be a game-changer in meeting the demand for hard-to-source parts, complex structures, patient-specific implants, and other tools. This will enable enterprises, especially small and medium enterprises (SMEs), to leverage advanced 3D printing technology and produce high-value, customised goods that can respond to market-specific demands in real-time, offering new levels of flexibility and efficiency that conventional factories are unable to meet.
In the ceremony, Professor Dong SUN, JP, Secretary for Innovation, Technology and Industry, HKSAR Government, said, “3D printing enables the development of more micro-factories in Hong Kong.  Compared to the traditional one, micro-factories require less land and materials, generate higher efficiency but less waste. This best suits Hong Kong’s condition, where land resources are limited and labour costs are relatively high. The establishment of this 3D printing technology centre is undoubtedly a good answer to show how we make use of state-of-the-art technology to promote advanced manufacturing and new industrialisation in Hong Kong. I am confident that Hong Kong’s manufacturing industry will reach new heights, and ‘Made in Hong Kong’ will continue to be a reputable and brilliant international brand. I look forward to more representative technology companies from all around the globe, such as HP to team up with our I&T quangoes, such as HKPC, bringing talents, technologies and machinery to Hong Kong to redefine Hong Kong’s manufacturing industry and drive high-quality economic growth.”  
Hon Sunny TAN, Chairman of HKPC, said, “We’re very pleased to form this research collaboration with HP, underscoring the confidence that global technology firms have in Hong Kong’s strengths in innovation. As an international innovation and technology centre, Hong Kong can be a paragon of the micro-factory city of the future that provides Hong Kong’s answer to develop new productive forces and set a fine example in Asia and across the globe to pursue innovation-driven, sustainable development. Hong Kong’s unique conditions make it particularly suitable for the development of micro-factories. The vibrant ecosystem in Hong Kong, combined with the robust supply chains in the Guangdong-Hong Kong-Macao Greater Bay Area, will provide an excellent pilot transformation base for the development of micro-factories, with significant implications for economies in Asia and worldwide.”
Mr Ramon PASTOR, Global Head of 3D Metals at HP Personalisation & 3D Printing, said, “It’s truly exciting to witness the launch of this collaborative effort between HKPC and HP, which aligns perfectly with our vision of leveraging Additive Manufacturing to drive industrialisation. This initiative not only showcases our dedication to technological advancement but also our shared vision for propelling industry innovation forward. HP believes in the immense potential of Hong Kong’s technology sector. We are also glad to bring in Pro-Technic Machinery Ltd. (Pro-Technic) to provide local support for our collaboration with HKPC.”
The Centre is planned to open in September, serving as a networking hub to promote closer collaboration among academia, research institutions and industries, empowering diverse sectors to grasp market trends. In addition to application development, the Centre will also provide consultancy and training services, driving advancements and propelling the 3D printing industry, as well as other industries utilising 3D printing technologies, forward.
About Hong Kong Productivity Council 
The Hong Kong Productivity Council (HKPC) is a multi-disciplinary organisation established by statute in 1967, to promote productivity excellence through relentless drive of world-class advanced technologies and innovative service offerings to support Hong Kong enterprises. Being a key enabler of Industry 4.0 and Enterprise 4.0, HKPC strives to facilitate new industrialisation in Hong Kong, as well as bolstering Hong Kong to be an international innovation and technology centre and a smart city. The Council offers comprehensive innovative solutions for Hong Kong industries and enterprises, enabling them to achieve resources and productivity utilisation, effectiveness and cost reduction, and enhance competitiveness in both local and overseas marketplace. The Council partners and collaborates with local industries and enterprises and world-class R&D institutes to develop applied technology solutions for value creation. It also benefits a variety of sectors through product innovation, technology transfer, and commercialisation, bringing enormous business opportunities ahead. HKPC’s world-class R&D achievements have been widely recognised over the years, winning an array of local and overseas accolades.   
In addition, HKPC offers SMEs and startups immediate and timely assistance in coping with the ever-changing business environment, and strengthens talent nurturing and Hong Kong’s competitiveness with FutureSkills training for enterprises and academia to enhance digital capabilities and TechEd competencies.
For more information, please visit HKPC’s website: www.hkpc.org/en.  
About HP
HP Inc. (NYSE: HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 countries, HP delivers a wide range of innovative and sustainable devices, services and subscriptions for personal computing, printing, 3D printing, hybrid work, gaming, and more. For more information, please visit: http://www.hp.com.
Photo – https://mma.prnewswire.com/media/2406486/Photo_HKPC_and_HP_Launch_Joint_Technology_Centre_in_Hong_Kong_on_Advanced_3D_Printing.jpg

View original content:https://www.prnewswire.co.uk/news-releases/hkpc-and-hp-launch-joint-technology-centre-in-hong-kong-on-advanced-3d-printing-302138081.html

Continue Reading

Artificial Intelligence

ShipFlex from Locus Expands Global Carrier Network to Over 160 Carriers, Enhancing Multi-Carrier Parcel Management Capabilities

Published

on

shipflex-from-locus-expands-global-carrier-network-to-over-160-carriers,-enhancing-multi-carrier-parcel-management-capabilities

SAN FRANCISCO, May 7, 2024 /PRNewswire/ — Locus.sh, a global AI-powered integrated logistics management SaaS company, announced its global carrier network for ShipFlex (its innovative multi-carrier parcel management solution) now has over 160 carriers. This significant expansion reflects ShipFlex’s continued commitment to redefining flexibility and efficiency in logistics for shippers globally.

“By efficiently broadening our carrier network globally, ShipFlex stands out as a marketing-leading offering that has the agility to cater to shippers’ fulfillment needs across diverse geographies, industries, fulfillment models, and fleet types, among other variables crucial to shippers,” said Nishith Rastogi, Founder and CEO of Locus.
For retail, manufacturing, and consumer packaged goods (CPG) companies that outsource their deliveries, ShipFlex stands out as a powerful ally as it optimizes fulfilmment operations across captive, contracted, outsourced and even hybrid fleets. “These sectors prize end-to-end optimization of operations and costs to deliver exemplary customer experiences. By automating decision-making around selecting third-party delivery providers, ShipFlex empowers shippers to meet both current and future demands efficiently across diverse fleet types used by these industries,” added Rastogi.
ShipFlex automates multi-carrier deliveries tailored to specific business constraints regarding cost, speed, and efficiency. The platform simplifies the logistics of sourcing additional capacity and assigning shipments, all from a single dashboard.
The solution enhances dispatch flexibility with its capacity to integrate various carriers easily. It provides end-to-end visibility of the order journey, including real-time status updates and customer notifications, ensuring a top-notch post-purchase experience and minimizing delivery re-attempts.
About Locus
Locus’ order-to-delivery AI-powered dispatch and transport management software helps enterprises transform their logistics from cost centers to revenue generators through advanced optimization algorithms and intuitive workflow automation. Backed by GIC Singapore, Tiger Global, and Qualcomm Ventures, it has helped 200+ global customers across industries – Unilever, Nestle, BlueDart-DHL, etc. – execute over 1 billion deliveries across USA, Southeast Asia, the Middle East, and the Indian subcontinent.
www.locus.sh 
Photo: https://mma.prnewswire.com/media/2405170/ShipFlex.jpg Logo : https://mma.prnewswire.com/media/1832388/Locus_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/shipflex-from-locus-expands-global-carrier-network-to-over-160-carriers-enhancing-multi-carrier-parcel-management-capabilities-302136663.html

Continue Reading

Artificial Intelligence

Metacon and Siemens enter into collaboration for the manufacture of systems for green hydrogen production

Published

on

metacon-and-siemens-enter-into-collaboration-for-the-manufacture-of-systems-for-green-hydrogen-production

STOCKHOLM, May 7, 2024 /PRNewswire/ — Metacon AB (publ) and Siemens AB have signed a Memorandum of Understanding to enter into a partnership with the aim of accelerating the manufacturing of hydrogen production systems in Sweden, for the European market.

At the beginning of the year, Metacon announced that the company has been granted exclusive rights for the manufacture of complete electrolysis plants based on the partner PERIC’s world-leading technology for pressurized alkaline electrolysis modules (stacks). One of the key components of PERIC’s alkaline technology is efficient and proven 5 MW modules with over 10 years of operating data. Metacon also has access to the 10 MW module that PERIC recently launched and which today, in terms of power and production, is one of the world’s largest. The rights apply to most European countries and mean that Metacon can start from a proven technology that has been developed and refined for over 60 years, and make the adaptations required to match the requirements for safety and automation found in European standards for hydrogen production. With the exclusive right, Metacon now aims to become one of the market leaders in Europe for this type of large-scale hydrogen plants.
The joint MoU means that Siemens will become a technology partner to Metacon to contribute with its solid experience in delivering products, solutions and services in automation, power distribution, electrification, instrumentation, building technology and drives. Siemens will also be able to contribute with its wide range of digital services and software for optimisation, standardisation and simulation during both the manufacturing and operational phases of hydrogen plants.
“Hydrogen is an important piece of the puzzle in the industrial, energy and transport sectors to become CO2 neutral, and is the focus of Siemens’ global investment in Power-to-X. The partnership with Metacon marks a milestone in our quest to create a more sustainable world by, among other things, developing innovative solutions for the energy sector,” says Mikael Kraft, Head of Factory Automation and Sales at Siemens Digital Industries.
“Metacon has big plans for the investment in the manufacture and sale of large-scale electrolysis plants to, among others, the basic industry, the wind power sector and the transport sector in Europe. I have a hard time imagining a better partner on such a journey than Siemens. With its world-leading portfolio of technology, expertise and long-standing experience of similar projects, this partnership gives us the opportunity to both accelerate and optimize central parts of our unique Gigafactory project,” says Christer Wikner, CEO and President, Metacon.
For further information, please contact Christer Wikner, by phone 0707-647389 or e-mail [email protected]
About Metacon
Metacon AB (publ) develops and manufactures energy systems for the production of fossil-free “green” hydrogen. The products in the Reforming business area are based, among other things, on a patented technology that generates hydrogen through so-called catalytic steam reforming of biogas or other hydrocarbons. The development of Metacon’s reforming products is done within the wholly owned subsidiary Metacon S.A in Patras, Greece. The business is focused on catalytic process chemistry and advanced reformers for high-efficiency hydrogen production.
Metacon also offers complete electrolysis plants and integrated refueling stations for green hydrogen, a large and globally growing area for the production of green hydrogen. Electrolysis is a process of driving a chemical reaction to split water by adding electricity. If the electricity used is non-fossil, the hydrogen will also be fossil-free and climate-neutral. Green hydrogen can be used in sectors such as transport, basic industry and the real estate sector, with a better environment and climate as a result. www.metacon.com
About Siemens
Siemens AG (Berlin and Munich) is a technology company with a focus on industry, infrastructure, transport and healthcare. From more resource-efficient factories, resilient supply chains, and smarter buildings and grids, to cleaner and more convenient transportation and advanced healthcare, the company is developing technologies to create real value for customers and users. By combining the real and digital worlds, Siemens empowers its customers to transform their businesses and markets, helping them transform the lives of billions of people. Siemens owns a majority stake in the listed company Siemens Healthineers, a global leading medical device provider that is shaping the future of healthcare.
In the 2023 financial year ended September 30, 2023, the Siemens Group generated revenues of €77.8 billion and net profit of €8.5 billion. As of September 30, 2023, the company had approximately 320,000 employees worldwide. During the same period, Siemens in Sweden generated revenues of SEK 6.9 billion and employed approximately 1,500 people. For more information, see www.siemens.com and www.siemens.se. 
For more information see:www.metacon.com | X: @Metaconab | LinkedIn: www.linkedin.com/company/metaconab
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/metacon-ab/r/metacon-and-siemens-enter-into-collaboration-for-the-manufacture-of-systems-for-green-hydrogen-produ,c3974861
The following files are available for download:
https://mb.cision.com/Main/17030/3974861/2782927.pdf
PM Metacon Siemens en
 

View original content:https://www.prnewswire.co.uk/news-releases/metacon-and-siemens-enter-into-collaboration-for-the-manufacture-of-systems-for-green-hydrogen-production-302138039.html

Continue Reading

Trending